Abstract Background: The mechanisms through which HTLV-1 leads to and maintains damage in the central nervous system of patients undergoing HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) are still poorly understood. In recent years, increasing evidence indicates that, not only lympho...
Segundo OMS, em 2013 aproximadamente 35 milhões de pessoas no Mundo estavam infectadas pelo HIV e destes, aproximadamente 24,7 milhões viviam na África Subsariana. Em Moçambique, a prevalência é de 11,5% na população com 15-49 anos de idade. O aumento da prevalência do HIV na década de 80, prov...
The expansion of HIV antiretroviral therapy into decentralized rural settings will increasingly require simple point-of-care (POC) diagnostic tests that can be used without laboratory infrastructure and technical skills. New POC test devices are becoming available but decisions around which technologies ...
Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) is the etiological agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It has been estimated that 10–20 million people are infected worldwide, but no successful treatment is available. Recently, th...
: HIV-uninfected infants born to HIV-infected mothers (HIV-exposed uninfected, HEU) have been
described to have immune alterations as compared to unexposed infants. This study sought to characterize T-cell
populations after birth in HEU infants and unexposed infants living in a semirural area in southern...
Background: Recent data have shown that HTLV-1 is prevalent among HIV positive patients in Mozambique, although the impact of HTLV-1 infection on HIV disease progression remains controversial. Our aim was to determine the phenotypic profile of T lymphocytes subsets among Mozambican patients co-infected b...
The candidate malaria vaccine RTS,S/AS02A is a recombinant protein containing part of the circumsporozoite protein (CSP) sequence of Plasmodium falciparum, linked to the hepatitis B surface antigen and formulated in the proprietary adjuvant system AS02A. In a recent trial conducted in children younger th...
